Extremity Medical
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$4.2Mgeneral payments (2019-2025)
$0.00research payments (2019-2025)
424clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
- Io Fix $442K associated (2023-2025)
- Omni $368K associated (2023-2025)
- Xmcp $367K associated (2023-2025)
- Axis $120K associated (2023-2025)
- Jones $79K associated (2023-2025)
- Io Freedom $75K associated (2023-2025)
- Ex Fix $63K associated (2023-2025)
- Joint Prep $59K associated (2023-2025)
- Omni Stable Af $55K associated (2023-2025)
- Carpalfix $52K associated (2023-2025)
- Kinematx $51K associated (2023-2025)
- Lapidus $51K associated (2023-2025)
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Christopher Digiovanni | Providence, RI | Foot and Ankle Surgery | $469,495.83 |
| Vincent Sammarco | Cincinnati, OH | Sports Medicine (Orthopaedic Surgery) | $329,911.72 |
| Jeffrey Brodie | Towson, MD | Foot and Ankle Surgery | $223,871.59 |
| Brian Donley | Cleveland, OH | Orthopaedic Surgery | $179,852.00 |
| Brian Adams | Iowa City, IA | Orthopaedic Surgery | $175,451.00 |
| Brian Straus | Irving, TX | Orthopaedic Surgery | $150,692.09 |
| William James | Columbia, SC | Foot and Ankle Surgery | $132,243.20 |
| William Adams | Greenfield, IN | Foot & Ankle Surgery | $128,219.17 |
| Otis Barron | New York, NY | Hand Surgery | $121,074.00 |
| Timothy Charlton | Los Angeles, CA | Foot and Ankle Surgery | $120,303.13 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.